Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-16
1997-04-22
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3135
Patent
active
056229887
ABSTRACT:
The present invention relates to the use of compounds of formula I ##STR1## wherein R.sup.1 is independently hydrogen, hydroxy, alkyl with 1 to 6 carbon atoms, acyloxy groups with 1 to 6 carbon atoms, alkyloxy with 1 to 6 carbon atoms or from 1 to 5 sugar moieties; and R.sup.2 is independently hydrogen, or alkyl with 1 to 6 carbon atoms, in the reduction of coagulation time in mammals.
REFERENCES:
Chemical Abstracts, vol. 99, No. 15, The Abstract No. 118903u (1983).
Chemical Abstracts, vol. 91, No. 24, The Abstract No. 198935d (1979).
Patent Abstracts of Japan, vol. 10, No. 85, C-336, Abstract of JP, A, 60-218382 (1985).
Rasmussen Frank W.
Rasmussen Mirella E.
Worsaae Helle
Agris, Esq. Cheryl H.
Chan Nicky
Novo Nordisk A S
Zelson, Esq. Zelson T.
LandOfFree
Use of a low molecular weight metabolite from fungus for reducin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a low molecular weight metabolite from fungus for reducin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a low molecular weight metabolite from fungus for reducin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342140